Brief: Genprex Announces Closing Of $7.5 Mln Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
July 21 (Reuters) - Genprex Inc GNPX.O :
* GENPREX ANNOUNCES CLOSING OF $7.5 MILLION REGISTERED
DIRECT
OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
Source text for Eikon: ID:nPnfsDnda
Further company coverage: GNPX.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Genprex
See all newsBrief: Genprex Announces Collaboration With Roche Diagnostics For Biomarker Assay Validation Studies
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Genprex Announces Ip Australia's Intent To Grant Patent For Reqorsa® Gene Therapy